ArticleThe CRISPR journal2019

Single-Step, High-Efficiency CRISPR-Cas9 Genome Editing in Primary Human Disease-Derived Fibroblasts.

Matteo Martufi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.